A pharmaceutically acceptable salt of (r)-(e)-2-(4-2-(5-(1-3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol compound for the treatment of cancer
PK201100338A0Undetermined Publication Date: 2011-05-14ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201100338
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2011-05-09
- Publication Date
- 2011-05-14
Need to check novelty before this filing date? Find Prior Art
No text content released.